SPONSOR
Universitair Ziekenhuis Brussel
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Recurrent Glioblastoma
Universitair Ziekenhuis Brussel is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Recurrent Glioblastoma.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universitair Ziekenhuis Brussel
How many clinical trials has Universitair Ziekenhuis Brussel sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Universitair Ziekenhuis Brussel, of which 1 are actively recruiting participants. These trials cover conditions including Recurrent Glioblastoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universitair Ziekenhuis Brussel research focus on?
Universitair Ziekenhuis Brussel clinical trials span Recurrent Glioblastoma. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universitair Ziekenhuis Brussel clinical trial?
To participate in a Universitair Ziekenhuis Brussel trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universitair Ziekenhuis Brussel trials with current recruitment status updated daily.
Clinical Trials by Universitair Ziekenhuis Brussel
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology